Anlotinib for metastasis soft tissue sarcoma: A randomized, double-blind, placebo-controlled and multi-centered clinical trial.

Author:

Chi Yihebali1,Yao Yang2,Wang Shusen3,Huang Gang4,Cai Qiqing5,Shang Guanning6,Wang Guowen7,Qu Guofan8,Wu Qiong9,Jiang Yu10,Song Jianmin11,Chen Jing12,Zhu Xia13,Cai Zhengdong14,Bai Chunmei15,Lu Yongkui16,Yu Zhihua17,Shen Jingnan18,Cai Jianqiang1

Affiliation:

1. National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China;

2. Affiliated Sixth People's Hospital, Shanghai Jiaotong University, Shanghai, China;

3. Sun Yat-sen University Cancer Center, Guangzhou, China;

4. Hunan Cancer Hospital, Changsha, China;

5. Henan Cancer Hospital, Zhengzhou, China;

6. Liaoning Cancer Hospital and Institute, Shenyang, China;

7. Tianjin Medical University Cancer Institute & Hospital, Tianjin, China;

8. Harbin Medical University Cancer Hospital, Harbin, China;

9. The First Affiliated Hospital of Bengbu Medical College, Bengbu, China;

10. Department of Medical Oncology, Cancer Center, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, China;

11. Gansu Provincial Cancer Hospital, Lanzhou, China;

12. Wuhan Union Hospital, Wuhan, China;

13. The First Affiliated Hospital of Fujian Medical University, Fuzhou, China;

14. The First People's Hospital Affiliated to Shanghai Jiaotong University, Shanghai, China;

15. Peking Union Medical College Hospital/ Chinese Academy of Medical Sciences, Beijing, China;

16. Affiliated Tumor Hospital of Guangxi Medical University, Nanning, China;

17. Jiangxi Cancer Hospital, Nanchang, China;

18. Department of Musculoskeletal Oncology, the First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China;

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Cancer Research,Oncology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3